MannKind (NASDAQ: MNKD) reported Q4 EPS of ($0.06), versus ($0.28) reported last year. Revenue for the quarter came in at $16 million, versus $4.5 million reported last year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,